Greenlight Analytical (GLA) provides a comprehensive in-house cannabis testing technology for Licensed Producers (LPs). We have revolutionized the testing market by eliminating the time consuming, labour intensive, and error prone sample preparation required by traditional devices. We deliver accuracy & performance unheard of in any other in-house technology.
GLA provides a data driven production tool to help optimize harvest & increase revenue by offering actionable insights allowing Licensed Producers to.
- Reduce unit cost ($/gram)
- Maximize yield (grams/sq. ft.)
- Maximize potency
- Provide a consistent customer experience
The Cannabis Market
The cannabis market has changed dramatically, licensed producers (LP)’s have pivoted from growth to efficiency and need tools to optimize all facets of production. GLA’s bench-top analyzer will allow LP’s to identify the optimal point at which crops reach their maximum quality; whether that’s taste, smell, potency, or some combination thereof; testing with GLA’s analyzer will allow producers to achieve maximum throughput for their facility.
GLA’s bench-top Chemical Analyzer, designed to be used in the grow-room, will allow producers to increase revenue by maximizing THC/CBD potency, and monitor terpenes and flavour compounds to create consistent strains for which customers will pay a premium.
GLA’s beach-head market; Cannabis and Derivatives (edibles, drinkables, CBD wellness products); will provide early revenue through sales to LP's. The value of the cannabis/CBD industry is expected to grow to $5.2B in Canada, and globally to $92.8B, by 2027, with a CAGR of 20%. Recurring revenue will be realized through proprietary data & software licenses, service & support contracts, and leasing.
Controlled and Precision Agriculture
Safety & Security sectors
Health Facilities & Hospitals
Our growth markets; Agriculture, Healthcare and Law Enforcement; will open up an $8B opportunity. With simple software and packaging changes, our analyzers will ensure product safety and consistency, empower medical personnel with critical information to save lives, and provide government regulators and revenue enforcement agencies with tools to ensure compliance with tax and supply chain regulations.